Upper digestive bleeding due to Dieulafoy's lesion during the postoperative period of aortocoronary bypass surgery in a patient treated with clopidogrel. Dieulafoy lesion is an abnormally large artery (a vessel that takes blood from the heart to other areas of the body) in the lining of the gastrointestinal system.‎Summary · ‎Cause · ‎Diagnosis · ‎Learn More. active bleeding. Multiple endoclips may be required if the Mallory-Weiss tear is long or wide. A Dieulafoy lesion is defined as active arterial bleeding or an.


Author: Admin
Country: Croatia
Language: English
Genre: Education
Published: 2 April 2014
Pages: 669
PDF File Size: 47.23 Mb
ePub File Size: 36.94 Mb
ISBN: 519-4-42967-627-6
Downloads: 68064
Price: Free
Uploader: Admin



This article has been cited by other articles in PMC. Lesions in the jejunoileum or colorectum have been increasingly reported. Lesions typically appear at endoscopy as pigmented protuberances from exposed vessel stumps, with minimal surrounding erosion and no ulceration lesion de dieulafoy vessel sans ulcer.

Dieulafoy's lesion

Dual endoscopic therapy of epinephrine injection followed by ablative or mechanical therapy appears to be effective. Although banding is reportedly highly successful, it entails a small risk of gastrointestinal perforation from banding deep lesion de dieulafoy tissue.

Therapeutic alternatives after failed endoscopic therapy include repeat endoscopic therapy, angiography, or surgical wedge resection.

Its serious nature makes it necessary to include it in the differential diagnosis of obscure GI bleeding. The aim of this study was to review lesion de dieulafoy current trends in the diagnosis and management of Dieulafoy's lesion.

Dieulafoy lesions and arteriovenous malformations

All retrieved papers were analysed and the findings are summarised in this lesion de dieulafoy. Currently, surgical intervention is kept for failure of therapeutic endoscopic or angiographic interventions and it should be guided by pre-operative localisation.

Surgery is the last resort for curative treatment. Physical Examination Tips to Guide Management.

Dieulafoy's lesion: current trends in diagnosis and management

Typically there are no physical examination findings to follow to look for lesion de dieulafoy besides for vital signs. The patient likely will produce melanic stools for the next several days.

In rare cases the patient might have a severe rebleed causing massive hematemesis. Lesion de dieulafoy CBC or hemoglobin and hematocrits should be followed for at least the first 24 hours as these will likely help in the management of transfusions.

One should remember that the hemoglobin usually lags behind the bleed, so the initial hemoglobin might lesion de dieulafoy be an accurate representation of blood loss both during a brisk bleed and after having a bleed stopped.

Lesion de dieulafoy patients should follow-up with an endoscopist and minimize their risk factors for any recurrent upper GI bleed. This would include avoidance of NSAIDS and alcohol as well as possibly being on acid-lowering medicines such as histamine 2 receptor H2 blockers and proton pump inhibitors.

Patients are usually placed on proton pump inhibitor lesion de dieulafoy followed by a continuous infusion at 8 milligrams mg an hour usually for up to 72 hours.

  • Dieulafoy lesions and arteriovenous malformations - Cancer Therapy Advisor

Management with Co-Morbidities Desmopressin can be used to provide temporary hemostasis in a bleeding patient who is uremic. People with intrinsic liver disease will likely need fresh lesion de dieulafoy plasma FFP or vitamin K to help reverse their coagulopathy in order to slow down the bleeding.

Systolic and Diastolic Heart Failure In patients with severe heart failure one will need to watch their oxygenation status as well as their volume status to make sure that they do lesion de dieulafoy become hypoxic while they are getting resuscitated.

Coronary Artery Disease or Peripheral Vascular Disease The benefit of holding antiplatelet agents will need to be weighed against the risk of lesion de dieulafoy coronary syndromes.


In addition, one might have a lower threshold in transfusing blood in patients with lesion de dieulafoy coronary disease. Diabetes or other Endocrine issues No change in standard management.

Malignancy No change in standard management.

Dieulafoy's lesion: current trends in diagnosis and management

Immunosuppression HIV, chronic steroids, etc. No change in standard management. Gastrointestinal or Nutrition Issues If patient is nutritionally deplete, supplemental lesion de dieulafoy K might need to be given.

Transitions of Care A.

Dieulafoy's lesion - Wikipedia

Sign-out considerations While Hospitalized. One should signout serial CBC testing during at least the first 24 hours with transfusion parameters. Anticipated Length of Stay. Lesion de dieulafoy patients with an uncomplicated Dieulafoy lesion should anticipate to stay at least 2 to 3 days.